Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2016

Open Access 01-12-2016 | Retraction Note

Retraction note: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues

Authors: Hossein Ajdarkosh, Masoomeh Dadpay, Emad Yahaghi, Elham Rostami Pirzaman, Amir Farshid Fayyaz, Ebrahim Khodaverdi Darian, Aram Mokarizadeh

Published in: Diagnostic Pathology | Issue 1/2016

Login to get access

Excerpt

The Editor-in-Chief and Publisher have retracted this article [1] because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2, 3]) and authorship manipulation. …
Literature
1.
Ajdarkosh H, Dadpay M, Yahaghi E, Pirzaman ER, Fayyaz AF, Darian EK, Mokarizadeh A. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Diagn Pathol. 2015;10:135.CrossRefPubMedPubMedCentral
2.
Zhang SL, Liu L. microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1. Exp Ther Med. 2014;9(2):579–84.PubMedPubMedCentral
3.
Zhang J-G, Shi Y, Hong D-F, Song M, Huang D, Wang C-Y, Zhao G. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway. Sci Rep. 2015;5:8087.CrossRefPubMedPubMedCentral
Metadata
Title
Retraction note: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues
Authors
Hossein Ajdarkosh
Masoomeh Dadpay
Emad Yahaghi
Elham Rostami Pirzaman
Amir Farshid Fayyaz
Ebrahim Khodaverdi Darian
Aram Mokarizadeh
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2016
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-016-0561-8

Other articles of this Issue 1/2016

Diagnostic Pathology 1/2016 Go to the issue

Retraction Note

Retraction note: Effect of platelet-rich plasma on the healing of cutaneous defects exposed to acute to chronic wounds: a clinico-histopathologic study in rabbits

Research

Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis

Methodology

Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma

Case Report

Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case

Short report

Occurrence and detection method evaluation of group B streptococcus from prenatal vaginal specimen in Northwest China

Research

Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study